Clinical experience with famciclovir against hepatitis B virus.

doi:10.1159/000150566

Back to search

Article

Clinical experience with famciclovir against hepatitis B virus.

Intervirology - 1 Jan 1997

Bartholomeusz A, Groenen L C, Locarnini S A

Abstract excerpt

Famciclovir (FCV, the oral form of penciclovir, PCV) is a potent antiviral agent of hepatitis B virus (HBV) and is currently in phase III clinical trials. In this review, we examine the outcome of FCV treatment in preventing recurrent HBV in patients post transplantation. Resistance to FCV has no...

Topics

2-Aminopurine
Administration, Oral
Amino Acid Sequence
Antiviral Agents
Drug Resistance, Microbial
Famciclovir
Genes, Viral
Hepatitis B
Hepatitis B virus
Humans
Liver Transplantation
Models, Molecular
Molecular Sequence Data
Mutation
Prodrugs
RNA-Directed DNA Polymerase

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.